tiprankstipranks
Trending News
More News >
Advanced Enzyme Technologies Ltd (IN:ADVENZYMES)
:ADVENZYMES
India Market
Advertisement

Advanced Enzyme Technologies Ltd (ADVENZYMES) Price & Analysis

Compare
1 Followers

ADVENZYMES Stock Chart & Stats


ADVENZYMES FAQ

What was Advanced Enzyme Technologies Ltd’s price range in the past 12 months?
Advanced Enzyme Technologies Ltd lowest stock price was ₹257.85 and its highest was ₹533.00 in the past 12 months.
    What is Advanced Enzyme Technologies Ltd’s market cap?
    Advanced Enzyme Technologies Ltd’s market cap is ₹35.80B.
      When is Advanced Enzyme Technologies Ltd’s upcoming earnings report date?
      Advanced Enzyme Technologies Ltd’s upcoming earnings report date is Nov 07, 2025 which is in 39 days.
        How were Advanced Enzyme Technologies Ltd’s earnings last quarter?
        Advanced Enzyme Technologies Ltd released its earnings results on Aug 02, 2025. The company reported ₹3.6 earnings per share for the quarter, beating the consensus estimate of N/A by ₹3.6.
          Is Advanced Enzyme Technologies Ltd overvalued?
          According to Wall Street analysts Advanced Enzyme Technologies Ltd’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Advanced Enzyme Technologies Ltd pay dividends?
            Advanced Enzyme Technologies Ltd pays a Quarterly dividend of ₹1.2 which represents an annual dividend yield of 1.64%. See more information on Advanced Enzyme Technologies Ltd dividends here
              What is Advanced Enzyme Technologies Ltd’s EPS estimate?
              Advanced Enzyme Technologies Ltd’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Advanced Enzyme Technologies Ltd have?
              Advanced Enzyme Technologies Ltd has 111,881,150 shares outstanding.
                What happened to Advanced Enzyme Technologies Ltd’s price movement after its last earnings report?
                Advanced Enzyme Technologies Ltd reported an EPS of ₹3.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.581%.
                  Which hedge fund is a major shareholder of Advanced Enzyme Technologies Ltd?
                  Currently, no hedge funds are holding shares in IN:ADVENZYMES

                  Company Description

                  Advanced Enzyme Technologies Ltd

                  Advanced Enzyme Technologies Ltd (ADVENZYMES) is a leading global company specializing in the research, development, and manufacturing of enzyme products. Serving a diverse range of sectors including pharmaceuticals, food processing, baking, animal nutrition, and textiles, ADVENZYMES is dedicated to providing innovative enzyme solutions that enhance productivity and sustainability. Its core products include enzymes for digestive health, nutritional supplements, and industrial applications, supporting a broad spectrum of consumer and industrial needs.

                  Advanced Enzyme Technologies Ltd (ADVENZYMES) Earnings & Revenues

                  ADVENZYMES Stock 12 Month Forecast

                  Average Price Target

                  ₹358.00
                  ▲(11.89% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"254":"₹254","513":"₹513","318.75":"₹318.8","383.5":"₹383.5","448.25":"₹448.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":358,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹358.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":358,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹358.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":358,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹358.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[254,318.75,383.5,448.25,513],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Sep<br/>2025","25":"Sep<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,338.7,340.18461538461537,341.66923076923075,343.15384615384613,344.6384615384615,346.1230769230769,347.6076923076923,349.0923076923077,350.5769230769231,352.0615384615385,353.54615384615386,355.03076923076924,356.5153846153846,{"y":358,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,338.7,340.18461538461537,341.66923076923075,343.15384615384613,344.6384615384615,346.1230769230769,347.6076923076923,349.0923076923077,350.5769230769231,352.0615384615385,353.54615384615386,355.03076923076924,356.5153846153846,{"y":358,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,338.7,340.18461538461537,341.66923076923075,343.15384615384613,344.6384615384615,346.1230769230769,347.6076923076923,349.0923076923077,350.5769230769231,352.0615384615385,353.54615384615386,355.03076923076924,356.5153846153846,{"y":358,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":512.02,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":464.8,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":367.51,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":344.76,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":324.32,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":255.42,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":282.3,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":281.12,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":303.57,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":324.85,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":324.85,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":360.25,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":338.7,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Dishman Carbogen Amcis Ltd.
                  Gufic Biosciences Limited
                  Morepen Laboratories Limited
                  RPG Life Sciences Limited
                  Sequent Scientific Limited
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis